Clinical Trial Update: Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating Lucanix in patients with stages II-IV non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Lucanix

Snippet

Sponsor: NovaRx Corporation | Conditions: Lung Neoplasm, Carcinoma, Bronchogenic | Phase 2 | Status: COMPLETED